4445211000001107: Xeloda 150mg tablets (Roche Products Ltd) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Xeloda 150mg tablets (Roche Products Ltd)
• \UK product\Virtual medicinal product\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \UK product\Virtual therapeutic moiety\Capecitabine\Product containing only capecitabine in oral dose form (medicinal product form)\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \UK product\Virtual therapeutic moiety\Capecitabine\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \UK product\Trade family\Xeloda\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing methyltransferase inhibitor\Product containing thymidylate synthase inhibitor\Product containing capecitabine\Capecitabine\Product containing only capecitabine in oral dose form (medicinal product form)\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing methyltransferase inhibitor\Product containing thymidylate synthase inhibitor\Product containing capecitabine\Capecitabine\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing methyltransferase inhibitor\Product containing thymidylate synthase inhibitor\Product containing capecitabine\Product containing capecitabine in oral dose form (medicinal product form)\Product containing only capecitabine in oral dose form (medicinal product form)\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing capecitabine\Capecitabine\Product containing only capecitabine in oral dose form (medicinal product form)\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing capecitabine\Capecitabine\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing capecitabine\Product containing capecitabine in oral dose form (medicinal product form)\Product containing only capecitabine in oral dose form (medicinal product form)\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing capecitabine\Capecitabine\Product containing only capecitabine in oral dose form (medicinal product form)\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing capecitabine\Capecitabine\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing capecitabine\Product containing capecitabine in oral dose form (medicinal product form)\Product containing only capecitabine in oral dose form (medicinal product form)\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing capecitabine\Capecitabine\Product containing only capecitabine in oral dose form (medicinal product form)\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing capecitabine\Capecitabine\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing pyrimidine analog and acting as antineoplastic agent (product)\Product containing capecitabine\Product containing capecitabine in oral dose form (medicinal product form)\Product containing only capecitabine in oral dose form (medicinal product form)\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)
• \Medicinal product\Product manufactured as oral dose form\Product containing capecitabine in oral dose form (medicinal product form)\Product containing only capecitabine in oral dose form (medicinal product form)\Product containing precisely capecitabine 150 milligram/1 each conventional release oral tablet\Xeloda 150mg tablets (Roche Products Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
18069301000001118	Xeloda 150mg tablets (Roche Products Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
18069401000001114	Xeloda 150mg tablets (Roche Products Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start